1117 related articles for article (PubMed ID: 8793654)
1. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
2. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
Lazova R; Tantcheva-Poor I; Sigal AC
J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
[TBL] [Abstract][Full Text] [Related]
3. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
Sigal AC; Keenan M; Lazova R
Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
[TBL] [Abstract][Full Text] [Related]
4. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
5. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
Radfar A; Stefanato CM; Ghosn S; Bhawan J
Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
[TBL] [Abstract][Full Text] [Related]
6. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic differences between uveal and cutaneous melanomas.
Iwamoto S; Burrows RC; Kalina RE; George D; Boehm M; Bothwell MA; Schmidt R
Arch Ophthalmol; 2002 Apr; 120(4):466-70. PubMed ID: 11934320
[TBL] [Abstract][Full Text] [Related]
8. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors.
King R; Googe PB; Weilbaecher KN; Mihm MC; Fisher DE
Am J Surg Pathol; 2001 Jan; 25(1):51-7. PubMed ID: 11145251
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma.
Iwamoto S; Odland PB; Piepkorn M; Bothwell M
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):725-31. PubMed ID: 8912568
[TBL] [Abstract][Full Text] [Related]
10. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi.
Shah IA; Gani OS; Wheler L
Pathol Res Pract; 1997; 193(7):497-502. PubMed ID: 9342756
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
Blessing K; Sanders DS; Grant JJ
Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
[TBL] [Abstract][Full Text] [Related]
12. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
[TBL] [Abstract][Full Text] [Related]
13. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.
Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW
Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798
[TBL] [Abstract][Full Text] [Related]
14. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
15. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.
Boyle JL; Haupt HM; Stern JB; Multhaupt HA
Arch Pathol Lab Med; 2002 Jul; 126(7):816-22. PubMed ID: 12088451
[TBL] [Abstract][Full Text] [Related]
16. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
17. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
Heegaard S; Jensen OA; Prause JU
Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
[TBL] [Abstract][Full Text] [Related]
20. New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma.
Winnepenninckx V; De Vos R; Stas M; van den Oord JJ
Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):319-25. PubMed ID: 14663357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
